期刊文献+

MicroRNA在非酒精性脂肪性肝病发病过程中作用的研究进展 被引量:1

Progress of microRNA in the development of non-alcoholic fatty liver disease
下载PDF
导出
摘要 微小RNA(microRNA,miRNA)是一种小的非编码RNA,参与机体的生理和病理反应。非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是以弥漫性肝细胞大泡性脂肪变性为主要特征的临床病理综合征。近年来,有报道称miRNA在肝脏炎症、纤维化和硬化中发挥了一定的作用,尤其是在NAFLD发生发展过程中,miRNA表达特点、致病机制、临床诊治中的意义等方面引起了较大关注,故本文对此进行综述。 MicroRNA is small non-coding RNA that participates in physiological and pathological reactions in human body.Non-alcoholic fatty liver disease(NAFLD)refers to the clinical pathological syndrome mainly characterized by diffuse bulbous steatosis of hepatocytes.Recently,it has been reported that microRNA plays a certain role in liver inflammation,fibrosis and sclerosis,especially in the development of NAFLD.It has attracted considerable attention in the aspects of microRNA expression characteristics,pathogenesis,significance in clinical diagnosis and treatment of NAFLD.Therefore,this article reviews those recent advances.
作者 何占娣 刘迎娣 HE Zhan-di;LIU Ying-di(Department of Gastroenterology,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China)
出处 《传染病信息》 2019年第4期374-379,共6页 Infectious Disease Information
关键词 非编码RNA 非酒精性脂肪性肝病 致病机制 纤维化 non-coding RNA non-alcoholic fatty liver disease pathogenesis fibrosis
  • 相关文献

参考文献3

二级参考文献21

  • 1Yusuf Yilmaz.Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?[J].World Journal of Hepatology,2012,4(12):332-334. 被引量:4
  • 2Shubham Shrivastava,Anupam Mukherjee,Ratna B Ray.Hepatitis C virus infection,microRNA and liver disease progression[J].World Journal of Hepatology,2013,5(9):479-486. 被引量:6
  • 3Katalin Jármay,Gizella Karácsony,András Nagy,Zsuzsa Schaff.Changes in lipid metabolism in chronic hepatitis C[J].World Journal of Gastroenterology,2005,11(41):6422-6428. 被引量:22
  • 4Miriam J Alter.Epidemiology of hepatitis C virus infection[J].World Journal of Gastroenterology,2007,13(17):2436-2441. 被引量:72
  • 5O.Waidmann,V.Bihrer,T.Pleli,H.Farnik,A.Berger,S.Zeuzem,B.Kronenberger,A.Piiper.Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection[J]. Journal of Viral Hepatitis . 2012 (2)
  • 6M.Estep,D.Armistead,N.Hossain,H.Elarainy,Z.Goodman,A.Baranova,V.Chandhoke,Z. M.Younossi.Differential expression of miRNAs in the visceral adipose tissue of patients with non‐alcoholic fatty liver disease[J].Alimentary Pharmacology & Therapeutics.2010(3)
  • 7LinZheng,Guo‐caiLv,JifangSheng,Yi‐daYang.Effect of miRNA‐10b in regulating cellular steatosis level by targeting PPAR‐α expression, a novel mechanism for the pathogenesis of NAFLD[J].Journal of Gastroenterology and Hepatology.2009(1)
  • 8Blanche Schroen,Stephane Heymans.MicroRNAs and Beyond: The Heart Reveals Its Treasures[J].Hypertension.2009(6)
  • 9Kenneth J. Livak,Thomas D. Schmittgen.Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 ?ΔΔ C T Method[J].Methods.2001(4)
  • 10Donglai Ma,Xuanchen Tao,Feng Gao,Chengjuan Fan,Dequan Wu.miR-224 functions as an onco-miRNA in hepatocellular carcinoma cellsby activating AKT signaling[J]. Oncology Letters . 2012 (3)

共引文献35

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部